Substance, use in relation to COVID-19: a sco** review

N Kumar, K Janmohamed, K Nyhan, SS Martins… - Addictive …, 2022 - Elsevier
Background We conducted a sco** review focused on various forms of substance use
amid the pandemic, looking at both the impact of substance use on COVID-19 infection …

COVID-19 and substance use in adolescents

LH Lundahl, C Cannoy - Pediatric Clinics, 2021 - pediatric.theclinics.com
Adolescence is a critical period for social and emotional development. Important tasks
during this time include fashioning a social identity, develo** a degree of emotional and …

Impact of the COVID-19 pandemic on opioid overdose deaths: a spatiotemporal analysis

R Ghose, AM Forati, JR Mantsch - Journal of Urban Health, 2022 - Springer
The effects of the opioid crisis have varied across diverse and socioeconomically defined
urban communities, due in part to widening health disparities. The onset of the COVID-19 …

Comparison of characteristics of deaths from drug overdose before vs during the COVID-19 pandemic in Rhode Island

A Macmadu, S Batthala, AMC Gabel… - JAMA network …, 2021 - jamanetwork.com
Importance The rate of deaths from overdose has increased during the COVID-19 pandemic,
and recent US overdose mortality rates have been markedly high. However, scant data are …

Emergency department visits for nonfatal opioid overdose during the COVID-19 pandemic across six US health care systems

WE Soares III, ER Melnick, B Nath, G D'Onofrio… - Annals of Emergency …, 2022 - Elsevier
Study objective People with opioid use disorder are vulnerable to disruptions in access to
addiction treatment and social support during the COVID-19 pandemic. Our study objective …

[HTML][HTML] Surging racial disparities in the US overdose crisis

J Friedman, L Beletsky… - American Journal of …, 2022 - Am Psychiatric Assoc
As the four-decade long overdose crisis enters its “fourth wave”—characterized by
polysubstance use of potent, illicitly manufactured synthetic opioids, psychostimulants, and …

Telehealth for opioid use disorder treatment in low-barrier clinic settings: an exploration of clinician and staff perspectives

SV Aronowitz, E Engel-Rebitzer, A Dolan… - Harm reduction …, 2021 - Springer
Background The majority of individuals with opioid use disorder (OUD) face access barriers
to evidence-based treatment, and the COVID-19 pandemic has exacerbated the United …

Substitution of nonpharmacologic therapy with opioid prescribing for pain during the COVID-19 pandemic

B Lee, KC Yang, P Kaminski, S Peng… - JAMA network …, 2021 - jamanetwork.com
Importance During the pandemic, access to medical care unrelated to COVID-19 was limited
because of concerns about viral spread and corresponding policies. It is critical to assess …

[HTML][HTML] Substance use during COVID-19 pandemic: impact on the underserved communities

NC Chacon, N Walia, A Allen, A Sciancalepore… - Discoveries, 2021 - ncbi.nlm.nih.gov
The number of overdose deaths are on the rise all over the world. An estimate of 93,000
drug overdose deaths have been estimated in the United States in 2020. COVID-19 …

“In their mind, they always felt less than”: The role of peers in shifting stigma as a barrier to opioid use disorder treatment retention

MS Anvari, MB Kleinman, EC Massey… - Journal of substance …, 2022 - Elsevier
Introduction A substantial, national need exists for culturally acceptable, accessible opioid
use disorder (OUD) treatment. Medication for opioid use disorder (MOUD) is regarded as …